Literature DB >> 3891496

Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine.

J Holmgren, M Lindblad, P Fredman, L Svennerholm, H Myrvold.   

Abstract

Extraction of lipids from human small intestinal epithelial cells or brush borders removed specific binding sites for cholera toxin completely, but only about 50% of the receptor sites for Escherichia coli heat-labile enterotoxin. Both cholera toxin and E. coli heat-labile enterotoxin bound strongly to ganglioside GM1 in the lipid extract and, to a lesser extent, to another monosialoganglioside and to GD1b. The results suggest that E. coli heat-labile enterotoxin binds to both ganglioside and glycoprotein receptor sites of the human small intestinal epithelium, whereas cholera toxin binding was restricted to the ganglioside receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891496     DOI: 10.1016/0016-5085(85)90741-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  26 in total

1.  Characterization of an anti-idiotypic MoAb bearing an internal image of the receptor-binding epitope of cholera toxin.

Authors:  G P Lucas; C L Cambiaso; J P Vaerman
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 2.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

3.  Binding of cholera toxin to pig intestinal mucosa glycosphingolipids: relationship with the ABO blood group system.

Authors:  F R Bennun; G A Roth; C G Monferran; F A Cumar
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract.

Authors:  Frederik W van Ginkel; Raymond J Jackson; Naoto Yoshino; Yukari Hagiwara; Daniel J Metzger; Terry D Connell; Hong L Vu; Michael Martin; Kohtaro Fujihashi; Jerry R McGhee
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro.

Authors:  K M Hedberg; B Dellheden; C J Wikstrand; P Fredman
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

6.  The different inhibiting effect of cholera toxin on two leukemia cell lines does not correlate with their toxin binding capacity.

Authors:  A Giuliani; E Calappi; E Mineo; M G Neri; A Gallina; A Pessina
Journal:  Mol Cell Biochem       Date:  1995-11-22       Impact factor: 3.396

7.  Contributions of edema factor and protective antigen to the induction of protective immunity by Bacillus anthracis edema toxin as an intranasal adjuvant.

Authors:  Alexandra Duverger; Jeanne-Marie Carré; Junbae Jee; Stephen H Leppla; Estelle Cormet-Boyaka; Wei-Jen Tang; Daniel Tomé; Prosper N Boyaka
Journal:  J Immunol       Date:  2010-10-15       Impact factor: 5.422

8.  Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.

Authors:  H C Krivan; G F Clark; D F Smith; T D Wilkins
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

9.  Selection of a WEHI-3B leukemia cell subclone resistant to inhibition by cholera toxin.

Authors:  Augusto Pessina; Attilia Giuliani; Cristina Croera; Paola Foti; Lucia Mascolo; Giuseppina Gagliardi; Maria Grazia Neri
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

10.  Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate.

Authors:  Jin Hur; John Hwa Lee
Journal:  Clin Vaccine Immunol       Date:  2010-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.